Additionally, inhibiting SSRP1 has been shown to suppress the migration and invasion of glioma cells.37 These observations suggest that SSRP1 may contribute to the aggressive behavior of GBM cells, making it a potential therapeutic target for combating the disease. This evidence concerns the gene SSRP1 and glioma.